This page shows Iperionx (IPX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Iperionx passes 2 of 9 financial strength tests. 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Iperionx generates $0.62 in operating cash flow (-$21.8M OCF vs -$35.3M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Iperionx reported -$35.3M in net income in fiscal year 2025. This represents a decrease of 61.8% from the prior year.
Cash & Balance Sheet
Iperionx generated -$38.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 64.1% from the prior year.
Iperionx held $54.8M in cash against $3.9M in long-term debt as of fiscal year 2025.
Iperionx had 320M shares outstanding in fiscal year 2025. This represents an increase of 24.4% from the prior year.
Margins & Returns
Iperionx's ROE was -38.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.3 percentage points from the prior year.
Capital Allocation
Iperionx invested $17.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 238.0% from the prior year.
IPX Income Statement
| Metric | Q2'26 | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
IPX Balance Sheet
| Metric | Q2'26 | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $129.2M+23.0% | $105.0M-9.3% | $115.8M+108.9% | $55.4M+62.8% | $34.0M+49.3% | $22.8M+26.7% | $18.0M+81.6% | $9.9M |
| Current Assets | $69.6M+18.2% | $58.9M-25.3% | $78.8M+89.6% | $41.5M+76.3% | $23.6M+84.7% | $12.8M+8.3% | $11.8M+101.7% | $5.8M |
| Cash & Equivalents | $65.8M+20.1% | $54.8M-28.9% | $77.1M+132.6% | $33.2M+91.3% | $17.3M+45.2% | $11.9M+4.4% | $11.4M+101.6% | $5.7M |
| Inventory | $426K | $0 | $0-100.0% | $17K | N/A | $0 | N/A | N/A |
| Accounts Receivable | $1.2M+40.2% | $823K-15.8% | $977K-57.5% | $2.3M-14.9% | $2.7M+1084.3% | $228K+170.4% | $84K+274.8% | $23K |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $21.0M+66.4% | $12.6M+22.4% | $10.3M+151.2% | $4.1M+5.9% | $3.9M+72.6% | $2.2M-14.5% | $2.6M+5.3% | $2.5M |
| Current Liabilities | $17.3M+104.9% | $8.4M+26.3% | $6.7M+118.7% | $3.1M+16.2% | $2.6M+59.4% | $1.6M-10.1% | $1.8M-11.9% | $2.1M |
| Long-Term Debt | $4.5M+13.3% | $3.9M+9.4% | $3.6M+250.6% | $1.0M-15.9% | $1.2M+114.8% | $568K-25.4% | $761K+101.3% | $378K |
| Total Equity | $108.2M+17.0% | $92.4M-12.4% | $105.5M+105.6% | $51.3M+70.1% | $30.2M+46.7% | $20.6M+33.7% | $15.4M+107.2% | $7.4M |
| Retained Earnings | -$144.0M-31.8% | -$109.2M-21.2% | -$90.1M-22.0% | -$73.9M-17.8% | -$62.7M-20.1% | -$52.2M-20.0% | -$43.5M-25.2% | -$34.8M |
IPX Cash Flow Statement
| Metric | Q2'26 | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
IPX Financial Ratios
| Metric | Q2'26 | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 4.03-3.0 | 6.99-4.8 | 11.80-1.8 | 13.62+4.6 | 8.97+1.2 | 7.74+1.3 | 6.43+3.6 | 2.81 |
| Debt-to-Equity | 0.040.0 | 0.040.0 | 0.03+0.0 | 0.02-0.0 | 0.04+0.0 | 0.03-0.0 | 0.050.0 | 0.05 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
Is Iperionx profitable?
No, Iperionx (IPX) reported a net income of -$35.3M in fiscal year 2025.
How much debt does Iperionx have?
As of fiscal year 2025, Iperionx (IPX) had $54.8M in cash and equivalents against $3.9M in long-term debt.
What is Iperionx's return on equity (ROE)?
Iperionx (IPX) has a return on equity of -38.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Iperionx's free cash flow?
Iperionx (IPX) generated -$38.8M in free cash flow during fiscal year 2025. This represents a -64.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Iperionx's operating cash flow?
Iperionx (IPX) generated -$21.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Iperionx's total assets?
Iperionx (IPX) had $105.0M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Iperionx's capital expenditures?
Iperionx (IPX) invested $17.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Iperionx's current ratio?
Iperionx (IPX) had a current ratio of 6.99 as of fiscal year 2025, which is generally considered healthy.
What is Iperionx's debt-to-equity ratio?
Iperionx (IPX) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Iperionx's return on assets (ROA)?
Iperionx (IPX) had a return on assets of -33.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Iperionx's cash runway?
Based on fiscal year 2025 data, Iperionx (IPX) had $54.8M in cash against an annual operating cash burn of $21.8M. This gives an estimated cash runway of approximately 30 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Iperionx's Piotroski F-Score?
Iperionx (IPX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Iperionx's earnings high quality?
Iperionx (IPX) has an earnings quality ratio of 0.62x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.